Biotechs target Alzheimer’s

(USA) A number of leading biotechnology companies are focussing their efforts on conquering Alzheimer's. Last week we reported M3 Biotechnology is developing a drug with the potential to halt the disease....

New system could short circuit cancer

MIT researchers have created a synthetic gene circuit system that uses the immune system to fight cancer at its source. The circuit, encoded in DNA, triggers a therapeutic response to two 'specific cancer ma...